Naltrexone implant for opioid relapse prevention
Part of Mental health clinical trials.
This study tests a long-acting implant that releases naltrexone slowly over time to help prevent relapse in people with opioid use disorder. The implant is placed under the skin in a minor procedure and may help you stay opioid-free.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old
- You have been diagnosed with opioid use disorder in the past 12 months
- You have completed opioid withdrawal (no longer using opioids)
- You are currently seeking relapse prevention treatment
- You are willing to have a small implant placed under the skin of your abdomen
- You are willing to use birth control (if you are a woman who can become pregnant)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a combination of buprenorphine (through your care plan) and a monthly extended-release naltrexone (XR-NTX) shot can help prevent opioid relapse. It may help people who are ready to move toward a naltrexone-based relapse-prevention treatment after detox.
This study tests a faster way to start buprenorphine (a medication for opioid use disorder) by using naloxone to briefly trigger mild withdrawal. This could help people get started on treatment more comfortably and quickly.
This study compares two forms of a medication called buprenorphine (one is a pill you take under the tongue, the other is an injection) to see which works better for treating opioid use disorder. If you are eligible, you will receive one of these forms for a year and regular check-ups.
This trial tests whether a single treatment with ibogaine, a plant-based medicine, combined with a year of app and wearable support, helps people reduce or stop opioid use. It is for adults who have not had success with other treatments and are seeking a new option.
This trial tests whether starting buprenorphine using a low-dose plan is a safe and workable way to treat opioid use disorder. You may be able to join if you are 18+, have opioid use disorder, and can follow the study medication and visits.
This study tests a new way to support patients taking buprenorphine-naloxone for opioid addiction. It uses regular check-ins to help you and your doctor stay on track with your treatment.
Hear when a new Opioid Use Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.